Tagged Articles

Januvia 202 articles

Actos patients should seek safer alternatives

“The tests show you have type 2 diabetes.” Hearing those words from the doctor comes as a shock for thousands of Americans diagnosed with the disorder every year. As the once-rare disease grows in frequency, so do the number of options available to treat it. For the 26 million people in the U.S. living with type 2 diabetes, twelve individual drugs from six types of oral medications are available to regulate blood sugar levels when diet and lifestyle changes aren’t enough. So which medicine is better? The answer largely depends on the patient and the doctor, but mounting evidence suggests ... Read More

Diabetes drugs linked to pancreatitis, pancreatic cancer

Type 2 diabetics who take Januvia (sitagliptin) or Byetta (exenatide) to control their blood sugar levels may be at greater risk for developing pancreatitis and pancreatic cancer, and users of Byetta may also be at risk for thyroid cancer, a preliminary study suggests. The study, conducted by researchers at the Larry L. Hillblom Islet Research Center at the University of California, Los Angeles, involved data from the Food and Drug Administration (FDA) adverse event database for the years 2004-2009. When compared to other treatments, a six-fold increase of pancreatitis was found in patients who took either Januvia or Byetta. A ... Read More